다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Korean journal of urology, v.54 no.7, 2013년, pp.477 - 481
Seo, Yumi (Department of Urology, Dankook University College of Medicine, Cheonan, Korea.) , Lee, Gilho (Department of Urology, Dankook University College of Medicine, Cheonan, Korea.)
AI-Helper
PurposeEnterococcus faecalis is one of the most common pathogens linked to chronic bacterial prostatitis (CBP). Owing to a limited number of previous studies addressing this topic, we aimed to determine the drug resistance patterns of E. faecalis strains isolated from CBP patients.Materials and Meth...
1 Naber KG Busch W Focht J The German Prostatitis Study Group Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up Int J Antimicrob Agents 2000 14 143 149 10720805
2 Nickel JC Shoskes DA Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome BJU Int 2010 106 1252 1263 20946349
3 Sharp VJ Takacs EB Powell CR Prostatitis: diagnosis and treatment Am Fam Physician 2010 82 397 406 20704171
4 Meares EM Jr Bacterial prostatitis vs "prostatosis". A clinical and bacteriological study JAMA 1973 224 1372 1375 4634177
5 Weidner W Schiefer HG Krauss H Jantos C Friedrich HJ Altmannsberger M Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients Infection 1991 19 Suppl 3 S119 S125 2055646
7 Panagopoulos P Antoniadou A Kanellakopoulou K Tsiodras S Katsarolis I Papadopoulos A Fluoroquinolone treatment of chronic bacterial prostatitis: a prospective cohort study J Chemother 2009 21 317 321 19567353
8 Milingos S Creatsas G Messinis J Lolis D Kaskarelis D Treatment of chronic prostatitis by consecutive per os administration of doxycycline, sulfamethoxazole/trimethoprim, and cephalexin Int J Clin Pharmacol Ther Toxicol 1983 21 301 305 6604038
9 Baumuller A Antimicrobials for the treatment of bacterial prostatitis. Historical developments and current trends Scand J Urol Nephrol Suppl 1987 104 97 99 3326159
10 Thakkinstian A Attia J Anothaisintawee T Nickel JC α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome BJU Int 2012 110 1014 1022 22471591
11 Dalhoff A Weidner W Diffusion of ciprofloxacin into prostatic fluid Eur J Clin Microbiol Infect Dis 1988 7 438 439 3137058
12 Lee G Cho YH Shim BS Lee SD Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study J Korean Med Sci 2010 25 1205 1209 20676334
13 Jang WH Yoo DH Park SW Prevalence of and risk factors for levofloxacin-resistant E. coli isolated from outpatients with urinary tract infection Korean J Urol 2011 52 554 559 21927703
14 Krieger JN Nyberg L Jr Nickel JC NIH consensus definition and classification of prostatitis JAMA 1999 282 236 237 10422990
15 Nickel JC Prostatitis: evolving management strategies Urol Clin North Am 1999 26 737 751 10584615
16 Meares EM Stamey TA Bacteriologic localization patterns in bacterial prostatitis and urethritis Invest Urol 1968 5 492 518 4870505
17 Krieger JN Ross SO Limaye AP Riley DE Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis Urology 2005 66 721 725 16230124
18 Lee KS Choi JD Chronic prostatitis: approaches for best management Korean J Urol 2012 53 69 77 22379583
19 Nickel JC Downey J Clark J Ceri H Olson M Antibiotic pharmacokinetics in the inflamed prostate J Urol 1995 153 527 529 7815638
20 Chen J Chen RR Huang HS Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate J Formos Med Assoc 2001 100 548 552 11678006
21 Grabe M Forsgren A Bjork T Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection Eur J Clin Microbiol 1986 5 211 212 2424755
22 Drusano GL Preston SL Van Guilder M North D Gombert M Oefelein M A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin Antimicrob Agents Chemother 2000 44 2046 2051 10898674
23 Charalabopoulos K Karachalios G Baltogiannis D Charalabopoulos A Giannakopoulos X Sofikitis N Penetration of antimicrobial agents into the prostate Chemotherapy 2003 49 269 279 14671426
24 Dunn BL Stamey TA Antibacterial concentrations in prostatic fluid. 1. Nitrofurantoin J Urol 1967 97 505 507 6066945
25 Dyderski S Sokołowski W Gentamicin level in the prostate and its pharmacokinetics in patients with benign prostatic hypertrophy Pol Tyg Lek 1990 45 517 519 1705021
26 Oosterlinck W Defoort R Renders G The concentration of sulphamethoxazole and trimethoprim in human prostate gland Br J Urol 1975 47 301 304 1095105
27 Schaeffer AJ Darras FS The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin J Urol 1990 144 690 693 2201796
28 Fowler JE Jr Antimicrobial therapy for bacterial and nonbacterial prostatitis Urology 2002 60 6 Suppl 24 26 12521585
29 Sharer WC Fair WR The pharmacokinetics of antibiotic diffusion in chronic bacterial prostatitis Prostate 1982 3 139 148 7045835
30 Quinones D Goni P Rubio MC Duran E Gomez-Lus R Enterococci spp. isolated from Cuba: species frequency of occurrence and antimicrobial susceptibility profile Diagn Microbiol Infect Dis 2005 51 63 67 15629231
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.